Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis.

Neurol Neuroimmunol Neuroinflamm

Service de Neurologie, Centre Hospitalier Universitaire (CHU) Nantes, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigation Clinique (CIC), Center for Research in Transplantation, Nantes Université.

Published: March 2025

Background And Objectives: Older studies reported an increased risk of relapse after in vitro fertilization (IVF) in women with multiple sclerosis (MS), which has not been confirmed by more recent works. All these studies had several limitations, such as small sample sizes, absence of a control population, or lack of neurologic validation of the relapses. The aim of this study was to determine the risk of relapse after IVF in women with MS.

Methods: This retrospective cohort study included all women with MS who underwent IVF between 2009 and 2019 and a control group of women with MS who did not undergo IVF matched on age, MS duration, number of relapses, and MS-specific treatments in the previous year. Data on MS (disease duration, treatments, and relapses) were from the French MS Registry (OFSEP), whereas data on IVF (number of procedures, stimulation protocol type, and outcomes) were from the French national health insurance database. For this, the 2 databases were linked by indirect matching.

Results: In total, 115 women with MS underwent 199 IVF procedures (mean age at first IVF: 33.9 ± 4.0 years; 45.2% had ≥2 IVF procedures), and 175 IVFs (88.0%) could be matched to specific patients. The risk of relapse in the 3 months after index date was the same in both IVF group and control group (0.06 relapse per patient-year), as confirmed also by the before-after analysis in the IVF group (0.06 vs 0.08).

Discussion: This study, using a 10-year clinical and administrative dataset, did not find any increased risk of relapse after IVF. The maintenance of disease-modifying therapies until IVF was a determining factor in reducing the risk of relapse.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11820809PMC
http://dx.doi.org/10.1212/NXI.0000000000200371DOI Listing

Publication Analysis

Top Keywords

risk relapse
24
ivf
12
relapse vitro
8
vitro fertilization
8
women multiple
8
multiple sclerosis
8
increased risk
8
ivf women
8
relapse ivf
8
women underwent
8

Similar Publications

Persistence and Recurrence of Primary Hyperparathyroidism.

Best Pract Res Clin Endocrinol Metab

March 2025

Division of Endocrinology and Metabolism, McMaster University, Hamilton, ON, Canada. Electronic address:

Persistent and recurrent primary hyperparathyroidism (PHPT) represent significant challenges in the management of PHPT. Persistent PHPT is defined as persistence of hypercalcemia following parathyroidectomy (PTX) or the recurrence of hypercalcemia within the first 6 months following surgery. Recurrent PHPT is defined as recurrence of hypercalcemia after 6 months following PTX and requires normalization of serum calcium prior to the recurrence.

View Article and Find Full Text PDF

[Merkel cell carcinoma: An update].

Bull Cancer

March 2025

Dermatologie, CHU de Tours, Tours, France; Réseau CARADERM, France.

Merkel cell carcinoma (MCC) is a rare skin cancer that mainly affects the elderly, and whose incidence is increasing. Although the exact origin of this cancer remains uncertain, research in recent years has revealed that MCC develops through two oncogenesis pathways: virally induced by the Merkel polyomavirus (80% of cases) and induced by mutations linked to ultraviolet rays (20% of cases). MCC is an aggressive cancer, with a high mortality rate and limited therapeutic options in advanced stage.

View Article and Find Full Text PDF

The development of antibiotic resistance and inadequate immune response in chronic inflammation pose significant challenges in treating chronic osteomyelitis. As accepted non-antibiotic antimicrobial therapies, sonodynamic therapy (SDT) and photothermal therapy (PTT) are recognized for their effectiveness in eliminating bacteria and promoting tissue repair, rendering them promising therapeutic strategies for treating bacterial infections and preventing the emergence of drug-resistant bacteria. However, the antimicrobial action and efficacy in promoting tissue repair depend on the activation status of the host immune system.

View Article and Find Full Text PDF

Background: Post-chemotherapy retroperitoneal lymph node dissection (pcRPLND) is integral to multimodal treatment of patients with metastatic non-seminomatous germ cell tumors (NSGCT). We review pathologic and long-term outcomes of pcRPLND following first-line chemotherapy with a focus on residual mass size and primary tumor histology. Our goal was to identify new predictive approaches that can refine surgical indications.

View Article and Find Full Text PDF

Ki67 as a proliferation marker: a study on odontogenic keratocysts and radicular cysts.

J Stomatol Oral Maxillofac Surg

March 2025

Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

Ki67 as a proliferation marker plays a critical role in assessing cellular activity in various pathological tissues, including cystic lesions. Odontogenic keratocysts (OKCs) and radicular cysts (RCs) are two common types of jaw cysts that exhibit distinct biological behaviors, particularly in their proliferative patterns. OKCs are known for their aggressive nature and high recurrence rate, while RCs are typically less aggressive and exhibit lower recurrence risk.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!